Carolina Aguilar

Carolina Aguilar is CEO and Co-Founder of INBRAIN Neuroelectronics, a health-tech company that develops neuroelectronic therapies using graphene brain interfaces with ultra-high density and resolution with the mission to decode neural signals to improve people’s lives
She has over 15 years of expertise in healthcare out of which she was 13 years in the European Headquarters of Medtronic in Switzerland, leading globally businesses in brain modulation and diabetes where she managed complex markets and large teams that generated high YoY growth and innovation. Carolina is passionate about creating solutions that improve the outcomes that matter to patients and drive healthcare sustainability. She won several awards and honors, such as the European Value Based Health Care Prize and the PMEA Patient Centricity Award, for delivering patient-centric and value-based models of care. Just recently INBRAIN got FDA breakthrough designation for their innovative neural platform. The company also won the Most Innovative Company of the Year in 2022 and has been featured in key media such as Sifted, Financial Times, Nature etc.